We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

There has never been a better time to buy GlaxoSmithKline plc, Persimmon plc and Admiral Group plc

GlaxoSmithKline plc (LON: GSK), Persimmon plc (LON: PSN) and Admiral Group plc (LON: ADM) are growing companies that produce a high income.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

If you are investing in shares, what do you look for? Well, I would say a key component is growth: increasing revenues and increasing earnings. And I would expect that a substantial proportion of those earnings to be paid out as dividends, leading to a high income for the stock.

So here I have picked three companies that have prospects for growth and a high dividend yield. One is a pharmaceutical company, one is a house builder, and the third  is an insurance firm, and I think there has never been a better time to buy all 3.

Should you buy Admiral Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Treading water

In the 1980s, I remember people talking about chemical company ICI as a barometer for British industry. If Britain did well, then so did ICI.

I feel a similar way about pharma giant GlaxoSmithKline (LSE: GSK) today. Its share price movements have tracked those of the FTSE 100, almost as if the index and the firm were running a 3-legged race.

During the torrid bear market of the past 16 years, GSK, like the FTSE 100, has been treading water, some times moving a little up, some times moving a little down. But as the next great bull market gradually gets underway, I expect this firm to rise, just as the FTSE 100 will.

A 2016 P/E ratio of 16.61 shows the stock is reasonably priced, and their is a dividend yield of 5.49% that adds to GSK’s appeal.

Unbeatable combination

Britain’s economy has recovered strongly, and this has led to a resurgent housing market. That’s why I have long advocated investing in house builders such as Persimmon (LSE: PSN). After the dark night of the Credit Crunch, house builder share prices have been recovering strongly. And yet you can still buy in at bargain prices.

Persimmon’s 2016 P/E ratio is predicted to be just 11.11, with a dividend yield of 5.19%. This is an unbeatable combination of growth and income, and I think this company would be a worthy addition to your portfolio.

Highly cash generative

The insurance industry, once seen as unexciting, has undergone a series of revolutions. Firstly, as phone-based insurance took over from traditional brokers, and then as online insurance firms and price comparison sites have grabbed much of the business.

Admiral Group (LSE: ADM) is one of the leading price comparison and online insurance companies worldwide, owning brands such as confused.com, Admiral and Diamond in the UK, as well as websites in Europe and North America.

This promises to be a fast growing area, as Admiral’s international businesses follow the lead from the UK, which has perhaps the most advanced insurance market in the world. And this company is well placed to take advantage.

That’s why Admiral’s share price has been trending steadily upwards, and a 2016 P/E ratio of 19.05 may seem fully priced, but the well-covered dividend yield of 5.01% shows that this is a highly cash generative firm that has bright long-term prospects.

Prabhat Sakya has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female couple boarding their plane at the airport to go on holiday.
Investing Articles

Can the Rolls-Royce share price reach £15.97 by the end of August?

The Rolls-Royce share price has had a solid run in the last year. Muhammad Cheema takes a look at whether…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 1,200% in 5 years, here’s why Nvidia could still be a brilliant value stock

An exciting new announcement that could reshape the PC industry has just pushed Nvidia stock... well, just about nowhere really.

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How investing £4.50 a day could set you on the way to a £1,505 monthly second income

How can UK stocks with high dividend yields help investors earn a meaningful second income from the price of a…

Read more »

Investing Articles

Up 103% with a P/E of 261 — is this FTSE 100 stock still worth buying?

One FTSE 100 stock is quietly moving higher while most investors are still looking elsewhere — is the market missing…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

The smart money thinks AI stocks look risky — but is there still a chance to buy?

According to fund managers, the AI trade is getting crowded. But they still seem to think it’s the place to…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Barclays shares are 11% below their 52-week high. Could they be a bit of a bargain to consider?

Overpriced or one of the FTSE 100’s hidden gems? James Beard takes a closer look at how the market is…

Read more »

Stack of one pound coins falling over
Investing Articles

Down 65% but yielding 6.7% – is this beaten-down UK stock now a generational bargain?

Harvey Jones says this UK stock is one of the worst FTSE 100 performers but there are sound reasons to…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is this FTSE stock really 46% undervalued?

Analysts reckon this FTSE stock should be worth nearly 50% more. James Beard considers why there’s so much positivity surrounding…

Read more »